Publications by authors named "Maria Condom"

Claim this Profile
F
First external validation of the FLIPI-L score in a single-center series of patients with follicular lymphoma.
Pablo Mozas, Andrea Rivero, Alfredo Rivas-Delgado, Juan Gonzalo Correa, Maria Condom

Hematol Oncol· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of Empirical Antibiotic Regimens on Mortality in Neutropenic Patients with Bloodstream Infection Presenting with Septic Shock.
Mariana Chumbita, Pedro Puerta-Alcalde, Carlota Gudiol, Nicole Garcia-Pouton, Júlia Laporte-Amargós, Maria Condom

Antimicrob Agents Chemother· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic ability of five clinical risk scores in follicular lymphoma: A single-center evaluation.
Pablo Mozas, Andrea Rivero, Alfredo Rivas-Delgado, Juan Gonzalo Correa, Maria Condom

Hematol Oncol· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The direct and indirect effects of COVID-19 pandemic in a real-life hematological setting.
Maria Condom, Alberto Mussetti, Clara Maluquer, Rocío Parody, Eva González-Barca

Cancer Rep (Hoboken)· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clonal relationship in multisited mucosa-associated lymphoid tissue lymphomas: a single-centre experience.
Maria Condom, Fina Climent, Davinia Fernández, Dolors Colomer, Mónica Lopez-Guerra

Br J Haematol· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of Telehealth for Domiciliary Follow-up After Hematopoietic Cell Transplantation During the COVID-19 Pandemic: Prospective Pilot Study.
Alberto Mussetti, Maria Queralt Salas, Maria Condom, Maite Antonio, Cristian Ochoa

JMIR Form Res· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Refractoriness to rituximab-based therapy and elevated serum B2-microglobulin predict for inferior survival in marginal zone lymphoma.
Marc Sorigue, Mark Bishton, Eva Domingo-Domenech, Andrew McMillan, Roosa Prusila, Maria Condom

Leuk Lymphoma· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis